Cortexyme Secures $1,000,000 Seed Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d330f5b1-b88c-4a64-8840-d961af6ebe8a - Date
10/6/2014 - Company Name
Cortexyme - Mailing Address
1609 Kirkham St. San Francisco, CA 94122 USA - Company Description
Cortexyme is developing novel treatments for altering the course of Alzheimer’s and other neurological diseases. - Website
http://www.cortexyme.com - Transaction Type
Venture Equity - Transaction Amount
$1,000,000 - Transaction Round
Seed - Proceeds Purposes
Cortexyme, which is developing novel therapeutics and diagnostics for Alzheimer’s disease and other neurodegenerative disorders, received a $500,000 investment from Dolby Family Ventures as part of $1 million in seed financing to fund their preclinical research. - M&A Terms
- Venture Investor
- Venture Investor
